Lineage Cell Therapeutics In shares owned by Nelson, Van Denburg & Campbell Wealth Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Nelson, Van Denburg & Campbell Wealth Management
from 13F filings
Historical chart of Nelson, Van Denburg & Campbell Wealth Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Nelson, Van Denburg & Campbell Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Nelson, Van Denburg & Campbell Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $270 | 300 | 0.90 |
| 2024-06-30 | $299 | 300 | 1.00 |
| 2024-03-31 | $475 | 321 | 1.48 |
| 2023-12-31 | $327 | 300 | 1.09 |
| 2023-09-30 | $354 | 300 | 1.18 |
| 2023-06-30 | $423 | 300 | 1.41 |
| 2023-03-31 | $450 | 300 | 1.50 |
More positions owned by Nelson, Van Denburg & Campbell Wealth Management
View all positions for Nelson, Van Denburg & Campbell Wealth Management